|Bid||91.41 x 800|
|Ask||91.50 x 800|
|Day's Range||91.94 - 94.40|
|52 Week Range||58.66 - 127.42|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 11, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||129.50|
A panel of Motley Fool contributors offers three ideas for healthcare stocks that will zoom higher in 2021, even if COVID takes a turn for the worse. Read more to see why you might want to buy shares of Pfizer (NYSE: PFE), Inari Medical (NASDAQ: NARI), and Novavax (NASDAQ: NVAX). George Budwell (Pfizer): American pharma titan Pfizer might not sound like a sexy pick among the present cohort of COVID vaccine players.
Inari Medical, Inc. (NARI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRVINE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will present at the Canaccord Genuity 41st Annual Growth Conference on Thursday, August 12, 2021 at 10:30 a.m. Eastern Time. About Inari Medical, Inc.Inari Medical, Inc. is a commercial-stage medical device compan